13829 studies found for:    Open Studies | "Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
2 Recruiting A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies, (for Example;   Chronic Lymphocytic Leukemia, Burkett's Lymphoma,;   Mantle Cell Lymphoma, Primary Lymphoma of the Central Nervous System,;   Marginal Zone B Cell Lymphoma);;   Any T-cell Malignancy;;   Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma,;   Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer;   Colorectal Adenocarcinoma, Non-small Cell Lung Cancer)
Intervention: Drug: CDX-1127
3 Recruiting Early Detection of Pancreatic Cystic Neoplasms
Conditions: Pancreatic Cysts;   Intraductal Papillary Mucinous Neoplasm;   Pancreatic Mucinous-Cystic Neoplasm;   Cystic, Mucinous and/or Serous Neoplasm;   Solid Pseudopapillary Tumour of the Pancreas
Intervention:
4 Recruiting A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Conditions: Neoplasms;   Neoplasms, Ovarian;   Neoplasms, Breast;   Advanced or Refractory Solid Malignancies
Interventions: Drug: DOXIL/CAELYX (doxorubicin) Treatment Sequence AB;   Drug: DOXIL/CAELYX (doxorubicin) Treatment Sequence BA
5 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;;   Rhabdomyosarcoma;;   Ewing's Sarcoma;;   Ewing's Tumor;;   Sarcoma, Ewing's;;   Sarcomas, Epitheliod;;   Sarcoma, Soft Tissue;;   Sarcoma, Spindle Cell;;   Melanoma;;   Malignant Melanoma;;   Clinical Oncology;;   Oncology, Medical;;   Pediatrics, Osteosarcoma;;   Osteogenic Sarcoma;;   Osteosarcoma Tumor;;   Sarcoma, Osteogenic;;   Tumors;;   Cancer;;   Neoplasia;;   Neoplasm;;   Histiocytoma;;   Fibrosarcoma;;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
6 Not yet recruiting Study of Safety and Efficacy of BYL719 With Everolimus or BYL719 With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors
Conditions: Neoplasms,;   Breast Neoplasms,;   Kidney Neoplasms,;   Pancreatic Neuroendocine Neoplasms
Interventions: Drug: BYL719;   Drug: Everolimus;   Drug: Exemestane
7 Recruiting Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms
Conditions: Neoplasms, Cystic, Mucinous, and Serous;   Pancreatic Neoplasms;   Ultrasonography, Interventional
Intervention: Procedure: EUS and/or ERCP with ethanol injections of pancreatic cyst
8 Recruiting A Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Conditions: Melanoma;   Breast Neoplasms;   Lobular Carcinoma;   Triple-negative Breast Cancer;   Pancreatic Adenocarcinoma;   Colorectal Cancer;   Head and Neck Cancer;   Other Tumor Types With Documented Genetic Alterations Upstream in the Wnt Signaling Pathway
Intervention: Drug: LGK974
9 Recruiting An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
Conditions: Malignant Solid Tumour;   Ovarian Cancer;   Triple Negative Breast Cancer;   Advanced Melanoma;   B-cell Malignancy, Low-grade
Interventions: Drug: E7449 alone;   Drug: E7449 plus TMZ;   Drug: E7449 plus carboplatin and paclitaxel
10 Not yet recruiting CC-486 (Oral Azacitidine) Bioequivalence Study in Patients With Solid Tumor or Hematologic Malignancies
Conditions: Hematological Neoplasms;   Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma;   Lymphoma;   Multiple Myeloma;   Acute Myeloid Leukemia;   Leukemia;   Myelodysplastic Syndromes;   Neoplasms;   Melanoma;   Breast Cancer;   Metastatic Breast Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Renal Cell Carcinoma;   Glioblastoma Multiforme;   Osteosarcoma;   Sarcoma;   Thyroid Cancer;   Genitourinary
Interventions: Drug: CC-486;   Drug: Vidaza
11 Recruiting Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
Conditions: Conjunctival Intraepithelial Neoplasia;   Corneal Intraepithelial Neoplasia
Interventions: Drug: Mitomycin C;   Drug: Interferon Alfa-2b
12 Recruiting The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence
Conditions: Vulvar Cancer;   Vulvar Intraepithelial Neoplasia
Interventions: Behavioral: standardized care (Intervention I);   Behavioral: Standardized care + WOMAN-PRO II program (Intervention II)
13 Not yet recruiting Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia
Condition: Cervical Intraepithelial Neoplasia
Intervention: Biological: GX-188E
14 Recruiting Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer
Conditions: Neoplasms,;   Metastatic Cancer,;   Non-Small Cell Lung Cancer;   Advanced Solid Malignancies
Interventions: Drug: AZD6244;   Drug: Docetaxel
15 Unknown  Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neuroblastoma;   Pheochromocytoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: yttrium Y 90-edotreotide
16 Recruiting Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
Conditions: Tumor;   Cancer;   Pain;   Malignant Solid Tumor;   Unresectable Malignant Neoplasm;   Hematologic Malignancy;   Multiple Myeloma;   Lymphoma;   Neoplasm Metastasis
Intervention: Drug: Sodium Bicarbonate
17 Recruiting Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm
Conditions: Mucinous Cystic Tumor With Moderate Dysplasia;   Mucinous Cystadenoma of Pancreas;   Mucinous Cystadenocarcinoma of Pancreas;   Benign Neoplasm of Pancreas
Intervention: Drug: Ethanol and Paclitaxel Injection
18 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
19 Recruiting Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia
Condition: Cervical Intraepithelial Neoplasia
Interventions: Drug: Topical Imiquimod;   Procedure: Conization
20 Recruiting A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Conditions: Urinary Bladder Neoplasms;   Carcinoma, Transitional Cell;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Pancreatic Ductal;   Tumor Virus Infections
Interventions: Drug: CC-486 plus Carboplatin;   Drug: CC-486 plus ABI-007;   Drug: CC-486

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years